Detalles de la búsqueda
1.
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
Clin Gastroenterol Hepatol
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365094
2.
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Clin Gastroenterol Hepatol
; 22(3): 572-580.e5, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734582
3.
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
Am J Gastroenterol
; 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534155
4.
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Hepatology
; 78(5): 1558-1568, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184202
5.
The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic area.
J Gastroenterol Hepatol
; 39(1): 193-201, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731071
6.
Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease.
J Gastroenterol Hepatol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38725327
7.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480009
8.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208843
9.
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
Clin Gastroenterol Hepatol
; 21(4): 1013-1022.e6, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35654298
10.
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort.
Virol J
; 20(1): 112, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268999
11.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol
; 20(4): 874-885.e4, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089852
12.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333150
13.
Body weight changes in treated hepatitis B patients switching to tenofovir alafenamideâ.
J Formos Med Assoc
; 121(7): 1273-1282, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625346
14.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123849
15.
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B.
J Infect Dis
; 223(1): 139-146, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32525978
16.
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
J Infect Dis
; 224(2): 294-302, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249474
17.
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
J Infect Dis
; 224(11): 1890-1899, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33999179
18.
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).
Gut
; 70(12): 2349-2358, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33303567
19.
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.
J Viral Hepat
; 28(5): 719-727, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33533547
20.
Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrence.
Liver Int
; 41(5): 956-968, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33346937